Neuroone Medical Technologies Corp (NMTC)

Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	40.88% 1.3773	0.9776	0.7418	0.6299	0.4662
Cost Of Revenue	38.74% 0.9869	0.7113	0.5481	0.3862	0.4347
Gross Profit	46.60% 0.3904	0.2663	0.1937	0.2437	0.0315
Operating Expenses	10.40% 3.2765	3.6568	3.3584	3.7539	3.5274
Benefits Costs and Expenses	2.09% 4.2324	4.3225	3.8769	4.0987	3.989
Costs And Expenses	2.09% 4.2324	4.3225	3.8769	4.0987	3.989
Depreciation and Amortization	3.82% 0.0609	0.0587	-	-	-
Operating Income/Loss	14.88% -2.8861	-3.3905	-3.1647	-3.5102	-3.4959
Income/Loss From Continuing Operations Before Tax	14.64% -2.8551	-3.3449	-3.1351	-3.4688	-3.5228
Income/Loss From Continuing Operations After Tax	14.64% -2.8551	-3.3449	-3.1351	-3.4688	-3.5228
Net Income/Loss	14.64% -2.8551	-3.3449	-3.1351	-3.4688	-3.5228
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7.98% 25.91	24.00	1.3806	17.58	16.41
Diluted Average Shares	7.98% 25.91	24.00	1.3806	17.58	16.41
Basic Earnings Per Share	21.43% -0.11	-0.14	-0.13	-0.20	-0.21
Diluted Earnings Per Share	21.43% -0.11	-0.14	-0.13	-0.20	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-